US Bancorp
IMNM icon

US Bancorp’s Immunome IMNM Stock Holding History

US Bancorp’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$363K Buy
17,129
+4,817
+39% +$103K ﹤0.01% 1781
2026
Q1 		$269K Buy
+12,312
New +$274K ﹤0.01% 1854
2025
Q3 		– Sell
-21
Closed -$195 – 4145
2025
Q2 		$195 Hold
21
– – ﹤0.01% 4079
2025
Q1 		$141 Buy
+21
New +$201 ﹤0.01% 4121
2024
Q4 		– Sell
-1,389
Closed -$20.3K – 4217
2024
Q3 		$20.3K Buy
1,389
+9
+0.7% +$128 ﹤0.01% 3122
2024
Q2 		$16.7K Hold
1,380
– – ﹤0.01% 3133
2024
Q1 		$34.1K Buy
+1,380
New +$28K ﹤0.01% 2879
2021
Q4 		– Sell
-112
Closed -$3K – 4156
2021
Q3 		$3K Buy
+112
New +$1.95K ﹤0.01% 3788

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

US Bancorp's IMNM Position: Q2 2026 in Review

US Bancorp increased its Immunome (IMNM) stake by 39% in Q2 2026, buying an estimated $103K and bringing the position to 17,129 shares worth $363K. The position accounts for ﹤0.01% of the portfolio, ranked #1781.

US Bancorp first reported a position in IMNM in Q3 2021 and has held it in 8 quarters since. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • US Bancorp held 17,129 shares of Immunome worth $363K as of Q2 2026.
  • US Bancorp bought 4,817 Immunome shares in Q2 2026, an estimated $103K.
  • Immunome made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #1781 holding.
  • US Bancorp first reported a position in Immunome in Q3 2021 and has held it in 8 quarters since.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.